Dr. Barry Dworkin

It is too soon to draw any conclusions about short/long term immunity based on COVID-19 antibody levels. Many unknown factors remain. Time should help with the answers in future studies.

Medical Mythbusting Commentary for October 14, 2020

Source:
Evidence mounts that immunity from COVID-19 antibodies has limits

Related posts:

  1. Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings.
  2. Still too early in the pandemic to determine how long immunity lasts after initial infection.
  3. Vulnerable populations to be the focus in a new Canadian COVID-19 antibody study.
  4. Study reports that people who had mild to moderate #COVID-19 have protective stable antibody levels five months after their infection. This finding and further studies to follow can help with public policy and vaccine development programs.